HCV core and NS3 proteins mediate toll like receptor induced innate immune response in corneal epithelium.

Autor: Rajalakshmy AR; L & T Microbiology Research Centre, Vision Research Foundation, Sankara Nethralaya, Chennai 600 006, India; Centre for Nanotechnology and Advanced Biomaterials, SASTRA, Thanjavur, India., Malathi J; L & T Microbiology Research Centre, Vision Research Foundation, Sankara Nethralaya, Chennai 600 006, India., Madhavan HN; L & T Microbiology Research Centre, Vision Research Foundation, Sankara Nethralaya, Chennai 600 006, India. Electronic address: drhnm@snmail.org.
Jazyk: angličtina
Zdroj: Experimental eye research [Exp Eye Res] 2014 Nov; Vol. 128, pp. 117-28. Date of Electronic Publication: 2014 Oct 01.
DOI: 10.1016/j.exer.2014.09.011
Abstrakt: Direct association of dry eye syndrome and hepatitis C virus (HCV) infection is a well established fact. In this context, the current study examines the in vitro corneal inflammatory response with respect to HCV core and NS3 antigens. Toll like receptors (TLRs) are pattern recognition receptors which can mediate innate immune response. In the present study, corneal epithelial cells responded to HCV core and NS3 proteins by secreting pro-inflammatory cytokines IL-8, IL-6 and TNF-α via TLR1, TLR2 and TLR6 mediated innate immune response. MyD88/NF-kB signalling was involved in pro-inflammatory cytokine production. Corneal epithelium synthesised nitric oxide (NO) via iNOS during HCV core and NS3 exposure. On later stages of inflammation, cells underwent apoptosis which lead to cell death. SiRNA mediated silencing of TLR1, TLR2 and TLR6 resulted in a significant down regulation of IL-8 and NO. In conclusion, this study indicates that HCV core and NS3 proteins are capable of inducing immune response in corneal epithelium which can potentiate the pathology of HCV associated dry eye condition. Blocking specific TLR response can have therapeutic application in controlling the inflammatory response associated with this dry eye condition.
(Copyright © 2014. Published by Elsevier Ltd.)
Databáze: MEDLINE